MENU
VYGR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Voyager Therapeutics (VYGR) Ownership - Who owns Voyager Therapeutics?
Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
75 Hayden Avenue
Phone
+1 857 259-5340
Employees
162
Web
https://www.voyagertherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
170.04M
P/E Ratio
6.00
Total Cash
266.68M
Projected Growth
N/A
Total Debt
43.73M
Revenue
80M
Risk (Beta)
1.55
Dividend Yield
N/A
Total Cash/Share
4.83
Total Debt/Equity
N/A
Revenue/Share
1.39 USD as % of share price
Fundamentals
VYGR
Capitalization
170M
P/E Ratio
6.00
Risk (Beta)
1.55
Dividend Yield
N/A
Total Cash
267M
Total Cash/Share
4.83
Total Debt
43.7M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.39%
Revenue
80M
ROE
N/A
Book Value
300M
P/B Ratio
0.57
Cash Flow
N/A
Earnings
-1.13
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
55K
Current Ratio
5.56
Current Revenue Per Employee
36500.00
Dividends Per Share - Security
N/A
EBITDA
-78.56M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-17.47
Shares Held By Institutions
267M
Shares Outstanding - Current
55.2M
Total Liabilities
93.3M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-45.503
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of gene therapies for fatal and debilitating diseases of the central nervous system
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
75 Hayden Avenue
Phone
+1 857 259-5340
Employees
162
Web
https://www.voyagertherapeutics.com